FDA Oks Improved Pacemaker

Monday, 06 May 2013 12:02 PM


  Comment  |
   Contact Us  |
|  A   A  
  Copy Shortlink
Medtronic Inc. (MDT) won U.S. regulatory approval for its Viva device used to resynchronize the beating of the heart and reduce hospitalizations for heart failure.
The permanently implanted device uses an algorithm to coordinate the heart’s 100,000 contractions each day, adjusting to varying demands of the body as the user goes through regular daily activities. The sophisticated system removes the need for doctors to calibrate the device manually and improves the battery life by 25 percent compared with older models, Minneapolis-based Medtronic said today in a statement.
SPECIAL: These 4 Things Happen Right Before a Heart Attack — Read More.

Significantly more heart-failure patients responded to treatment and they were 21 percent less likely to be hospitalized in the first year than expected based on studies of older devices, said David Steinhaus, Medtronic’s medical director for cardiac rhythm disease management. The improvements lead to $1,600 in cost savings per patient over the life of the device, he said.
“It’s more cost effective than the older technology, and even the older technology decreases hospitalizations and length of stay,” Steinhaus said in an interview. “These devices are designed to provide optimal therapy for patients, while providing economic benefits through fewer hospitalizations, fewer inappropriate shocks, and increased longevity.”
Patient Improvement
The product cleared for sale by the Food and Drug Administration is the first to make a marked improvement in the number of heart-failure patients who respond to treatment since the synchronization devices were approved more than a decade ago, Steinhaus said. Some doctors don’t refer their patients for evaluations needed to get the devices, and others don’t often implant them, for fear they may not help the patients feel better, he said.
“It’s really the first time we can say we’ve made a difference in response rates,” he said. “Nobody wants to go through the procedure and put this in a patient who isn’t going to feel better, even though we may be helping by stemming the progression of the disease. We expect this to become the standard of care in the United States.”
Medtronic is the world’s biggest maker of heart-rhythm devices.
SPECIAL: These 4 Things Happen Right Before a Heart Attack — Read More.

© Copyright 2014 Bloomberg News. All rights reserved.

  Comment  |
   Contact Us  |
  Copy Shortlink
Around the Web
Join the Newsmax Community
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
Retype Email:
Zip Code:
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Late Flu Wave Hits Northeast

Saturday, 19 Apr 2014 09:46 AM

A second, milder wave of flu is hitting the Northeast. Months ago, the flu season seemed to be winding down. But healt . . .

Singer Debbie Gibson Reveals Battle With Lyme Disease

Friday, 18 Apr 2014 17:07 PM

Singer Debbie Gibson says that he was diagnosed last year with Lyme disease, a tick-borne illness that can cause joint p . . .

Food Poisoning Strikes Food Safety Meeting

Friday, 18 Apr 2014 16:43 PM

Maryland health officials are investigating a suspected outbreak of food poisoning among government and business leaders . . .

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

America's News Page
©  Newsmax Media, Inc.
All Rights Reserved